These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8892911)

  • 1. Cell cycle stage-specific phosphorylation of the Epstein-Barr virus immortalization protein EBNA-LP.
    Kitay MK; Rowe DT
    J Virol; 1996 Nov; 70(11):7885-93. PubMed ID: 8892911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of major phosphorylation sites of Epstein-Barr virus nuclear antigen leader protein (EBNA-LP): ability of EBNA-LP to induce latent membrane protein 1 cooperatively with EBNA-2 is regulated by phosphorylation.
    Yokoyama A; Tanaka M; Matsuda G; Kato K; Kanamori M; Kawasaki H; Hirano H; Kitabayashi I; Ohki M; Hirai K; Kawaguchi Y
    J Virol; 2001 Jun; 75(11):5119-28. PubMed ID: 11333893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of protein kinases responsible for phosphorylation of Epstein-Barr virus nuclear antigen leader protein at serine-35, which regulates its coactivator function.
    Kato K; Yokoyama A; Tohya Y; Akashi H; Nishiyama Y; Kawaguchi Y
    J Gen Virol; 2003 Dec; 84(Pt 12):3381-3392. PubMed ID: 14645919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conserved regions in the Epstein-Barr virus leader protein define distinct domains required for nuclear localization and transcriptional cooperation with EBNA2.
    Peng R; Tan J; Ling PD
    J Virol; 2000 Nov; 74(21):9953-63. PubMed ID: 11024123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitosis-specific hyperphosphorylation of Epstein-Barr virus nuclear antigen 2 suppresses its function.
    Yue W; Davenport MG; Shackelford J; Pagano JS
    J Virol; 2004 Apr; 78(7):3542-52. PubMed ID: 15016877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conserved region CR2 of Epstein-Barr virus nuclear antigen leader protein is a multifunctional domain that mediates self-association as well as nuclear localization and nuclear matrix association.
    Tanaka M; Yokoyama A; Igarashi M; Matsuda G; Kato K; Kanamori M; Hirai K; Kawaguchi Y; Yamanashi Y
    J Virol; 2002 Feb; 76(3):1025-32. PubMed ID: 11773378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activation.
    Harada S; Kieff E
    J Virol; 1997 Sep; 71(9):6611-8. PubMed ID: 9261383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein-protein interactions between Epstein-Barr virus nuclear antigen-LP and cellular gene products: binding of 70-kilodalton heat shock proteins.
    Kitay MK; Rowe DT
    Virology; 1996 Jun; 220(1):91-9. PubMed ID: 8659132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus leader protein enhances EBNA-2-mediated transactivation of latent membrane protein 1 expression: a role for the W1W2 repeat domain.
    Nitsche F; Bell A; Rickinson A
    J Virol; 1997 Sep; 71(9):6619-28. PubMed ID: 9261384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The conserved domain CR2 of Epstein-Barr virus nuclear antigen leader protein is responsible not only for nuclear matrix association but also for nuclear localization.
    Yokoyama A; Kawaguchi Y; Kitabayashi I; Ohki M; Hirai K
    Virology; 2001 Jan; 279(2):401-13. PubMed ID: 11162796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ATM/ATR signaling effector Chk2 is targeted by Epstein-Barr virus nuclear antigen 3C to release the G2/M cell cycle block.
    Choudhuri T; Verma SC; Lan K; Murakami M; Robertson ES
    J Virol; 2007 Jun; 81(12):6718-30. PubMed ID: 17409144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic analysis of the Epstein-Barr virus-coded leader protein EBNA-LP as a co-activator of EBNA2 function.
    McCann EM; Kelly GL; Rickinson AB; Bell AI
    J Gen Virol; 2001 Dec; 82(Pt 12):3067-3079. PubMed ID: 11714985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EBNA-LP associates with cellular proteins including DNA-PK and HA95.
    Han I; Harada S; Weaver D; Xue Y; Lane W; Orstavik S; Skalhegg B; Kieff E
    J Virol; 2001 Mar; 75(5):2475-81. PubMed ID: 11160753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of EBNA-1 mRNA is regulated by cell cycle during Epstein-Barr virus type I latency.
    Davenport MG; Pagano JS
    J Virol; 1999 Apr; 73(4):3154-61. PubMed ID: 10074167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter.
    Peng R; Moses SC; Tan J; Kremmer E; Ling PD
    J Virol; 2005 Apr; 79(7):4492-505. PubMed ID: 15767449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus (EBV) nuclear antigen leader protein (EBNA-LP) forms complexes with a cellular anti-apoptosis protein Bcl-2 or its EBV counterpart BHRF1 through HS1-associated protein X-1.
    Matsuda G; Nakajima K; Kawaguchi Y; Yamanashi Y; Hirai K
    Microbiol Immunol; 2003; 47(1):91-9. PubMed ID: 12636258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The EBNA-3 gene family proteins disrupt the G2/M checkpoint.
    Krauer KG; Burgess A; Buck M; Flanagan J; Sculley TB; Gabrielli B
    Oncogene; 2004 Feb; 23(7):1342-53. PubMed ID: 14716295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation.
    Mannick JB; Cohen JI; Birkenbach M; Marchini A; Kieff E
    J Virol; 1991 Dec; 65(12):6826-37. PubMed ID: 1658376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical characterization of Epstein-Barr virus nuclear antigen 2A.
    Grässer FA; Haiss P; Göttel S; Mueller-Lantzsch N
    J Virol; 1991 Jul; 65(7):3779-88. PubMed ID: 1645792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early events in Epstein-Barr virus infection of human B lymphocytes.
    Alfieri C; Birkenbach M; Kieff E
    Virology; 1991 Apr; 181(2):595-608. PubMed ID: 1849678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.